Manulife (Manufacturers Life Insurance)
HRMY icon

Manulife (Manufacturers Life Insurance)’s Harmony Biosciences HRMY Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$600K Sell
21,430
-6
-0% -$197 ﹤0.01% 2069
2025
Q4 		$802K Buy
21,436
+41
+0.2% +$1.35K ﹤0.01% 1966
2025
Q3 		$590K Sell
21,395
-1,291
-6% -$44.5K ﹤0.01% 2132
2025
Q2 		$717K Buy
22,686
+532
+2% +$17.1K ﹤0.01% 1975
2025
Q1 		$735K Buy
22,154
+2,769
+14% +$99.3K ﹤0.01% 1950
2024
Q4 		$667K Buy
19,385
+2,144
+12% +$73.7K ﹤0.01% 2092
2024
Q3 		$690K Sell
17,241
-211
-1% -$7.41K ﹤0.01% 2111
2024
Q2 		$527K Sell
17,452
-477
-3% -$14.3K ﹤0.01% 2196
2024
Q1 		$602K Buy
17,929
+1,415
+9% +$45.4K ﹤0.01% 2123
2023
Q4 		$533K Sell
16,514
-568
-3% -$15.9K ﹤0.01% 2143
2023
Q3 		$560K Buy
17,082
+3,295
+24% +$114K ﹤0.01% 2077
2023
Q2 		$485K Buy
13,787
+2,526
+22% +$87.2K ﹤0.01% 2056
2023
Q1 		$368K Buy
11,261
+202
+2% +$9.2K ﹤0.01% 2200
2022
Q4 		$609K Buy
11,059
+290
+3% +$15.9K ﹤0.01% 1861
2022
Q3 		$477K Sell
10,769
-192
-2% -$9.37K ﹤0.01% 2012
2022
Q2 		$535K Buy
10,961
+1,011
+10% +$45.5K ﹤0.01% 2013
2022
Q1 		$484K Sell
9,950
-2,023
-17% -$82.5K ﹤0.01% 2225
2021
Q4 		$511 Buy
11,973
+500
+4% +$19.9K ﹤0.01% 2240
2021
Q3 		$440K Sell
11,473
-1,094
-9% -$35.2K ﹤0.01% 2386
2021
Q2 		$355K Buy
+12,567
New +$377K ﹤0.01% 2688

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s HRMY Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Harmony Biosciences (HRMY) stake by 0.03% in Q1 2026, selling an estimated $197 and leaving 21,430 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

Manulife (Manufacturers Life Insurance) first reported a position in HRMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $802K in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 21,430 shares of Harmony Biosciences worth $600K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 6 Harmony Biosciences shares in Q1 2026, an estimated $197.
  • Harmony Biosciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2069 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Harmony Biosciences in Q2 2021 and has held it in 20 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Harmony Biosciences position peaked at $802K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.